1. Medtech Insight
  2. >>Device Area
  3. >>Diagnostics

DiaSorin Completes $1.8bn Acquisition Of Luminex

 
• By Barnaby Pickering

The brokered deal will broaden DiaSorin’s offerings in the rapidly growing liquid diagnostics market, while also providing Luminex furthered access to markets outside of the US.

• Source: Alamy

Italian Diagnostics company DiaSorin SpA has completed its planned $1.8bn acquisition of Luminex, the company announced 14 July.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from In Vitro Diagnostics

More from Diagnostics